ZI
ZIVO Bioscience, Inc.
ZIVO · OTC
$3.11 -13.61% (-$0.49)
1M -22.64%
Market Cap $12.1M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 184.28x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
12 /100
Weak Gross margin 32.44%
FCF margin 3,790.06%
Net margin 8,388.36%
Quality
60 /100
Average ROIC 194.30%
Asset turnover 0.15x
ROA 1,241.30%
Debt
0 /100
High Current ratio 0.10x
Int. coverage -141.10x
Debt/Equity N/A
Stability
44 /100
Moderate Beta 0.11x
Profitable years 0
EPS volatility 10.38%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ZIVO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Bernard Payne
Employees
7
Headquarters
Troy
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report